JPMorgan Chase & Co. Issues Pessimistic Forecast for Quantinuum (NASDAQ:QNT) Stock Price

Quantinuum (NASDAQ:QNT) had its target price dropped by JPMorgan Chase & Co. from $97.00 to $80.00 in a research note issued to investors on Friday, Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 112.94% from the company’s current price.

QNT has been the subject of a number of other research reports. Jefferies Financial Group set a $85.00 price objective on shares of Quantinuum in a report on Wednesday, August 12th. Yorkville Ives started coverage on shares of Quantinuum in a report on Monday, October 5th. They set an “outperform” rating and a $60.00 target price on the stock. Sanford C. Bernstein reiterated a “hold” rating on shares of Quantinuum in a research report on Wednesday, August 12th. Weiss Ratings began coverage on Quantinuum in a research note on Monday, August 31st. They issued a “sell (d)” rating for the company. Finally, Needham & Company LLC reduced their price target on Quantinuum from $100.00 to $60.00 and set a “buy” rating on the stock in a research report on Friday. Thirteen investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $87.15.

Quantinuum Stock Performance

Shares of Quantinuum stock traded up $7.75 during trading on Friday, reaching $37.57. The company’s stock had a trading volume of 5,035,251 shares, compared to its average volume of 2,310,149. The firm’s 50-day moving average price is $43.74. Quantinuum has a 52 week low of $28.31 and a 52 week high of $86.79. The firm has a market capitalization of $9.89 billion and a price-to-earnings ratio of -134.18.

Quantinuum (NASDAQ:QNT) last released its quarterly earnings results on Thursday, November 5th. The company reported ($0.29) EPS for the quarter, topping analysts’ consensus estimates of ($0.99) by $0.70. The business had revenue of $9.05 million for the quarter. On average, equities analysts forecast that Quantinuum will post -4.76 EPS for the current year.

Institutional Trading of Quantinuum

Institutional investors and hedge funds have recently made changes to their positions in the company. Russell Investments Group Ltd. acquired a new stake in shares of Quantinuum during the 3rd quarter worth approximately $97,000. Pier 88 Investment Partners LLC bought a new position in Quantinuum in the third quarter valued at approximately $154,000. Fifth Third Bancorp raised its position in Quantinuum by 1,530.2% during the third quarter. Fifth Third Bancorp now owns 1,027 shares of the company’s stock valued at $49,000 after purchasing an additional 964 shares in the last quarter. State of Wyoming acquired a new position in Quantinuum during the third quarter valued at approximately $378,000. Finally, Flagship Harbor Advisors LLC bought a new stake in Quantinuum during the third quarter worth $206,000.

Key Headlines Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum beat third-quarter expectations, reporting a loss of $0.29 per share versus the $0.99 loss analysts expected. Revenue rose 233% year over year to $9.05 million, and the company raised its full-year 2026 revenue outlook. The report also noted that gross margin turned positive, although expenses are increasing. Quantinuum Q3 results and outlook
• Positive Sentiment: Commercial traction strengthened: Quantinuum said it secured its largest cloud agreement to date, expanded access through a hyperscaler and an Oracle beta launch, and saw platform adoption rise nearly 20% quarter over quarter. These developments could help build future revenue. Quantinuum Q3 results and outlook
• Positive Sentiment: The company outlined its Nexus developer-platform roadmap, connecting application development with future hardware, including its planned Apollo fault-tolerant quantum computer. The roadmap and reported technical milestones could strengthen Quantinuum’s longer-term competitive position. Nexus roadmap announcement
• Negative Sentiment: Some analysts lowered their forecasts and price targets after the results. Cantor Fitzgerald cut its target from $90 to $55 and Needham lowered its target from $100 to $60, though both retained positive ratings—Overweight and Buy, respectively. The cuts may temper enthusiasm despite the earnings beat. Analysts cut forecasts after Q3 results

Quantinuum Company Profile

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.